Certified by Founder Lodge
FogPharma
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $145,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
FogPharma is developing a new class of drugs to address the limitations of today’s precision medicines and achieve universal druggability. The company is pioneering the discovery, development
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 05 ,2024 | Series E | $145,000,000 |
Sixty Degree Capital
Johnson & Johnson
Foresite Capital
Nextech Invest
RA Capital Management, L.P.
Catalio Capital Management
Rock Springs Capital
Marshall Wace
Samsara BioCapital
SymBiosis(US)
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)